Literature DB >> 21223963

Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function.

C L Salanga1, T M Handel.   

Abstract

The first chemokine structure, that of IL-8/CXCL8, was determined in 1990. Since then, many chemokine structures have emerged. To the initial disappointment of structural biologists, the tertiary structures of these small proteins were found to be highly conserved. However, they have since proven to be much more interesting and diverse than originally expected. Somewhat like lego blocks, many chemokines oligomerize and there is significant diversity in their oligomeric forms and propensity to oligomerize. Chemokines not only interact with receptors where different oligomeric forms can induce different signaling responses, they also interact with glycosaminoglycans which can stabilize oligomers and other structures that would not otherwise form in solution. Although chemokine monomers and dimers yielded quickly to structure determination, structural information about larger chemokine oligomers, chemokines receptors, and complexes of chemokines with glycosaminoglycans and receptors has been more difficult to obtain, but recent breakthroughs suggest that this information will be forthcoming, especially with receptor structures. Equally important and challenging, will be efforts to correlate the structural information with function.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21223963      PMCID: PMC3089961          DOI: 10.1016/j.yexcr.2011.01.004

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  86 in total

1.  Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutants.

Authors:  V Appay; A Brown; S Cribbes; E Randle; L G Czaplewski
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

2.  Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium.

Authors:  Philipp von Hundelshausen; Rory R Koenen; Markus Sack; Sebastian F Mause; Wencke Adriaens; Amanda E I Proudfoot; Tilman M Hackeng; Christian Weber
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113

Review 3.  Chemokines and leukocyte traffic.

Authors:  M Baggiolini
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

4.  Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1.

Authors:  L S Mizoue; J F Bazan; E C Johnson; T M Handel
Journal:  Biochemistry       Date:  1999-02-02       Impact factor: 3.162

5.  Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.

Authors:  G S Kuschert; F Coulin; C A Power; A E Proudfoot; R E Hubbard; A J Hoogewerf; T N Wells
Journal:  Biochemistry       Date:  1999-09-28       Impact factor: 3.162

6.  Structure of a CXC chemokine-receptor fragment in complex with interleukin-8.

Authors:  N J Skelton; C Quan; D Reilly; H Lowman
Journal:  Structure       Date:  1999-02-15       Impact factor: 5.006

7.  Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

Authors:  M P Crump; J H Gong; P Loetscher; K Rajarathnam; A Amara; F Arenzana-Seisdedos; J L Virelizier; M Baggiolini; B D Sykes; I Clark-Lewis
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

8.  Chemokines and the arrest of lymphocytes rolling under flow conditions.

Authors:  J J Campbell; J Hedrick; A Zlotnik; M A Siani; D A Thompson; E C Butcher
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

9.  Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2.

Authors:  S Hemmerich; C Paavola; A Bloom; S Bhakta; R Freedman; D Grunberger; J Krstenansky; S Lee; D McCarley; M Mulkins; B Wong; J Pease; L Mizoue; T Mirzadegan; I Polsky; K Thompson; T M Handel; K Jarnagin
Journal:  Biochemistry       Date:  1999-10-05       Impact factor: 3.162

10.  Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B.

Authors:  C D Paavola; S Hemmerich; D Grunberger; I Polsky; A Bloom; R Freedman; M Mulkins; S Bhakta; D McCarley; L Wiesent; B Wong; K Jarnagin; T M Handel
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

View more
  85 in total

1.  Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.

Authors:  Urska Repnik; Amanda E Starr; Christopher M Overall; Boris Turk
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

2.  Antibody Neutralization of CXCL10 in Vivo Is Dependent on Binding to Free and Not Endothelial-bound Chemokine: IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES.

Authors:  Pauline Bonvin; Franck Gueneau; Vanessa Buatois; Maud Charreton-Galby; Stanley Lasch; Marie Messmer; Urs Christen; Andrew D Luster; Zoë Johnson; Walter Ferlin; Marie Kosco-Vilbois; Amanda Proudfoot; Nicolas Fischer
Journal:  J Biol Chem       Date:  2017-01-30       Impact factor: 5.157

3.  Identification of the pharmacophore of the CC chemokine-binding proteins Evasin-1 and -4 using phage display.

Authors:  Pauline Bonvin; Steven M Dunn; François Rousseau; Douglas P Dyer; Jeffrey Shaw; Christine A Power; Tracy M Handel; Amanda E I Proudfoot
Journal:  J Biol Chem       Date:  2014-09-29       Impact factor: 5.157

Review 4.  Role of the endothelial surface layer in neutrophil recruitment.

Authors:  Alex Marki; Jeffrey D Esko; Axel R Pries; Klaus Ley
Journal:  J Leukoc Biol       Date:  2015-05-15       Impact factor: 4.962

5.  Solution NMR characterization of WT CXCL8 monomer and dimer binding to CXCR1 N-terminal domain.

Authors:  Prem Raj B Joseph; Krishna Rajarathnam
Journal:  Protein Sci       Date:  2014-11-28       Impact factor: 6.725

Review 6.  Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?

Authors:  Mike Veenstra; Richard M Ransohoff
Journal:  J Neuroimmunol       Date:  2012-03-22       Impact factor: 3.478

7.  Distinct Differences in Structural States of Conserved Histidines in Two Related Proteins: NMR Studies of the Chemokines CXCL1 and CXCL8 in the Free Form and Macromolecular Complexes.

Authors:  Krishna Mohan Sepuru; Krishna Rajarathnam
Journal:  Biochemistry       Date:  2018-10-02       Impact factor: 3.162

8.  Alternative C-terminal helix orientation alters chemokine function: structure of the anti-angiogenic chemokine, CXCL4L1.

Authors:  Je-Hung Kuo; Ya-Ping Chen; Jai-Shin Liu; Alexandre Dubrac; Cathy Quemener; Hervé Prats; Andreas Bikfalvi; Wen-guey Wu; Shih-Che Sue
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

9.  A chemokine self-presentation mechanism involving formation of endothelial surface microstructures.

Authors:  Catherine Whittall; Oksana Kehoe; Sophie King; Antal Rot; Angela Patterson; Jim Middleton
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

10.  Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein.

Authors:  Sergio M Pontejo; Philip M Murphy
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.